Environmental modifiable risk factors for multiple sclerosis: Report from the 2016 ECTRIMS focused workshopMaria Pia Amato, Alberto Ascherio, Elisa Baldin et al.|Multiple Sclerosis Journal|2017Cited by 142
Expression of Vitamin D Receptor and Metabolizing Enzymes in Multiple Sclerosis—Affected Brain TissueJoost Smolders, Inge Huitinga|Journal of Neuropathology & Experimental Neurology|2013Cited by 128
Letter to the Editor: Vitamin D deficiency in COVID-19: Mixing up cause and consequenceJoost Smolders, Matthijs Kox, Jody van den Ouweland et al.|Metabolism|2020Cited by 98
Discontinuation of First-Line Disease-Modifying Therapy in Patients With Stable Multiple SclerosisEline M. E. Coerver, Eva Strijbis, Wing Hee Fung et al.|JAMA Neurology|2024Cited by 29
Reliability of serum neurofilament light and glial fibrillary acidic protein for detecting disease activity upon discontinuation of first-line disease-modifying therapy in stable multiple sclerosis (DOT-MS)Wing Hee Fung, Eva Strijbis, Mark HJ Wessels et al.|Journal of Neurology|2025Cited by 4